Zylox-Tonbridge Medical Technology Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jonathon Zhao
Chief executive officer
CN¥17.4m
Total compensation
CEO salary percentage | 17.3% |
CEO tenure | 11.8yrs |
CEO ownership | 12.9% |
Management average tenure | no data |
Board average tenure | 3.4yrs |
Recent management updates
Recent updates
Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon
Apr 23Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate
Jan 18Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?
Sep 21There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price
Aug 03We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jun 30Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?
Mar 08We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jan 19Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Jul 06We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely
Jan 27Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Oct 05CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | CN¥17m | CN¥3m | -CN¥79m |
Sep 30 2023 | n/a | n/a | -CN¥101m |
Jun 30 2023 | n/a | n/a | -CN¥124m |
Mar 31 2023 | n/a | n/a | -CN¥119m |
Dec 31 2022 | CN¥21m | CN¥3m | -CN¥114m |
Sep 30 2022 | n/a | n/a | -CN¥135m |
Jun 30 2022 | n/a | n/a | -CN¥155m |
Mar 31 2022 | n/a | n/a | -CN¥178m |
Dec 31 2021 | CN¥16m | CN¥2m | -CN¥200m |
Sep 30 2021 | n/a | n/a | -CN¥168m |
Jun 30 2021 | n/a | n/a | -CN¥135m |
Mar 31 2021 | n/a | n/a | -CN¥118m |
Dec 31 2020 | CN¥10m | CN¥1m | -CN¥100m |
Dec 31 2019 | CN¥1m | CN¥746k | -CN¥67m |
Compensation vs Market: Jonathon's total compensation ($USD2.43M) is above average for companies of similar size in the Hong Kong market ($USD414.63K).
Compensation vs Earnings: Jonathon's compensation has been consistent with company performance over the past year.
CEO
Jonathon Zhao (56 yo)
11.8yrs
Tenure
CN¥17,389,000
Compensation
Dr. Zhong Zhao also known as Jonathon, serves as Director of Avinger, Inc. since March 04, 2024. He is Founder of Zylox-Tonbridge Medical Technology Co., Ltd. and serves as its Chairman since November 06,...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 11.8yrs | CN¥17.39m | 12.87% CN¥ 425.2m | |
Senior VP of Sales & Marketing and Executive Director | 6.4yrs | CN¥10.53m | 0.12% CN¥ 4.1m | |
Senior VP | 5.6yrs | CN¥8.37m | 1.58% CN¥ 52.1m | |
Independent Non-Executive Director | 3.4yrs | CN¥200.00k | no data | |
Non-Executive Director | 3.7yrs | no data | no data | |
Non-Executive Director | 3.8yrs | no data | no data | |
Non Executive Director | 2.3yrs | no data | no data | |
Independent Non-Executive Director | 3.4yrs | CN¥200.00k | no data | |
Employee Supervisor | 3.4yrs | no data | no data | |
Supervisor | 2.3yrs | no data | no data | |
Chairman of the Board of Supervisors | less than a year | no data | no data | |
Independent Non-Executive Director | less than a year | no data | no data |
3.4yrs
Average Tenure
51yo
Average Age
Experienced Board: 2190's board of directors are considered experienced (3.4 years average tenure).